BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9687101)

  • 1. In-vitro, in-vivo and ex-vivo studies with oral beta-lactams against Streptococcus pneumoniae.
    Pérez-Trallero E; Alkorta M; García-Arenzana JM; Iturzaeta A; Gomariz M
    J Antimicrob Chemother; 1998 Jun; 41(6):629-34. PubMed ID: 9687101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin.
    Pérez-Trallero E; Alkorta M; Giménez MJ; Vicente D; Aguilar L
    J Chemother; 2001 Apr; 13(2):118-25. PubMed ID: 11330357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro and in vivo activities of cefpodoxime proxetil against penicillin-resistant Streptococcus pneumoniae].
    Kawada H; Kitayama A; Fukuoka T; Ishii C; Abe T; Kakuta M; Domon H; Ohya S; Utsui Y
    Jpn J Antibiot; 1999 Aug; 52(8):533-40. PubMed ID: 10587878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams.
    Spangler SK; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1997 Feb; 39(2):141-8. PubMed ID: 9069533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of a combination of two oral beta-lactams (cefpodoxime and amoxycillin) against Streptococcus pneumoniae isolates with reduced susceptibilities to penicillin.
    Johnson DM; Jones RN
    J Antimicrob Chemother; 1998 Oct; 42(4):555-7. PubMed ID: 9818764
    [No Abstract]   [Full Text] [Related]  

  • 6. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
    Goldstein FW
    Scand J Infect Dis; 1997; 29(3):255-7. PubMed ID: 9255885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2786-9. PubMed ID: 9420061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin].
    Fenoll A; Robledo O; Lerma M; Giménez MJ; Cebrián L; Casal J; Aguilar L; Gómez-Lus ML
    Rev Esp Quimioter; 2006 Mar; 19(1):39-44. PubMed ID: 16688290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J; Verbist L
    J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
    Calvo A; Amores R; Valero E; Sevillano D; Prieto J;
    Rev Esp Quimioter; 2001 Dec; 14(4):345-50. PubMed ID: 11856980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae.
    Lacy MK; Owens RC; Xu X; Nicolau DP; Quintiliani R; Nightingale CH
    Int J Antimicrob Agents; 1998 Nov; 10(4):279-83. PubMed ID: 9916901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
    Xiao YH; Gao L; Li Y; Lü Y; Liu J; Liu Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1867-71. PubMed ID: 15631795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bactericidal activity of newer oral cephalosporins in healthy volunteers.
    Dan M; Poch F; Edelman A; Asherov J; Hafely H; Atzmon Y
    J Antimicrob Chemother; 1998 Apr; 41(4):485-8. PubMed ID: 9598780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin.
    Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Chemother; 2008 Apr; 20(2):175-9. PubMed ID: 18467242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation.
    Sevillano D; Aguilar L; Alou L; Giménez MJ; González N; Echeverría O; Torrico M; Valdes L; Coronel P; Prieto J
    Chemotherapy; 2008; 54(2):84-90. PubMed ID: 18303256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances.
    Edlund C; Stark C; Nord CE
    J Antimicrob Chemother; 1994 Jul; 34(1):127-38. PubMed ID: 7961199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri.
    Kays MB; Wood KK; Miles DO
    Pharmacotherapy; 1999 Nov; 19(11):1308-14. PubMed ID: 10555936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.